JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$4.76B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.21B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$3.81B |
| 4 |
Apple
AAPL
|
+$3.39B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$3.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.48B |
| 2 |
S&P Global
SPGI
|
+$2.45B |
| 3 |
Coca-Cola
KO
|
+$1.73B |
| 4 |
Adobe
ADBE
|
+$1.59B |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.3B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.97% |
| 2 | Technology | 21.69% |
| 3 | Healthcare | 9.58% |
| 4 | Consumer Discretionary | 9.07% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4376
Genie Energy
GNE
$436M
| $712K | ﹤0.01% |
47,197
+8,377
| +22% | +$161K |
2022 Q4
5 quarters
|
|
|
ETNB
4377
DELISTED
89bio
ETNB
| $708K | ﹤0.01% |
60,813
-138,119
| -69% | -$1.53M |
2019 Q4
17 quarters
|
|
|
ZYXI
4378
DELISTED
Zynex
ZYXI
| $708K | ﹤0.01% |
57,220
+18,031
| +46% | +$216K |
2019 Q1
20 quarters
|
|
|
JNPR
4379
CALL
DELISTED
Juniper Networks
JNPR
| $704K | ﹤0.01% |
19,000
-41,800
| -69% | -$1.53M |
2023 Q2
3 quarters
|
|
|
ELEV
4380
DELISTED
Elevation Oncology
ELEV
| $704K | ﹤0.01% |
137,209
+136,968
| +56,833% | +$444K |
2022 Q4
5 quarters
|
|
4381
Zai Lab
ZLAB
$2.85B
| $704K | ﹤0.01% |
43,922
+3,038
| +7% | +$64K |
2020 Q1
16 quarters
|
|
4382
State Street SPDR MSCI EAFE Fossil Fuel Reserves Free ETF
EFAX
$489M
| $703K | ﹤0.01% |
16,907
-13,320
| -44% | -$531K |
2023 Q4
1 quarter
|
|
4383
CALL
United Parks & Resorts
PRKS
$1.48B
| $703K | ﹤0.01% |
12,500
-279,100
| -96% | -$14.2M |
2023 Q4
1 quarter
|
|
4384
PUT
Herbalife
HLF
$1.33B
| $702K | ﹤0.01% |
+69,900
| New | +$751K |
2024 Q1
0 quarters
|
|
4385
GoPro
GPRO
$258M
| $702K | ﹤0.01% |
314,963
+230,580
| +273% | +$616K |
2014 Q3
38 quarters
|
|
4386
Cibus
CBUS
$123M
| $702K | ﹤0.01% |
31,251
+24,115
| +338% | +$443K |
2023 Q1
4 quarters
|
|
4387
FT Vest US Equity Buffer ETF July
FJUL
$1.41B
| $702K | ﹤0.01% |
15,782
+15,199
| +2,607% | +$653K |
2023 Q4
1 quarter
|
|
4388
BioNTech
BNTX
$24.2B
| $701K | ﹤0.01% |
7,596
-231
| -3% | -$22.1K |
2020 Q1
16 quarters
|
|
4389
Stem
STEM
$42.2M
| $701K | ﹤0.01% |
15,993
+11,070
| +225% | +$615K |
2021 Q1
12 quarters
|
|
|
TBIL
4390
F/m US Treasury 3 Month Bill Fund
TBIL
$7.44B
| $700K | ﹤0.01% |
+13,999
| New | +$699K |
2024 Q1
0 quarters
|
|
4391
Park-Ohio Holdings
PKOH
$688M
| $700K | ﹤0.01% |
26,234
+4,312
| +20% | +$109K |
2013 Q2
43 quarters
|
|
4392
Fidelity Momentum Factor ETF
FDMO
$897M
| $700K | ﹤0.01% |
11,591
-597
| -5% | -$33.8K |
2023 Q2
3 quarters
|
|
4393
Ginkgo Bioworks
DNA
$776M
| $698K | ﹤0.01% |
15,054
-11,720
| -44% | -$607K |
2021 Q3
10 quarters
|
|
4394
AXT Inc
AXTI
$5.34B
| $698K | ﹤0.01% |
151,989
+150,541
| +10,396% | +$511K |
2017 Q3
26 quarters
|
|
4395
CALL
Roku
ROKU
$22.7B
| $697K | ﹤0.01% |
10,700
-13,600
| -56% | -$1.06M |
2023 Q3
2 quarters
|
|
|
BIG
4396
DELISTED
Big Lots, Inc.
BIG
| $697K | ﹤0.01% |
160,946
+140,097
| +672% | +$740K |
2013 Q2
43 quarters
|
|
4397
Anika Therapeutics
ANIK
$259M
| $695K | ﹤0.01% |
27,375
-2,974
| -10% | -$72K |
2015 Q4
33 quarters
|
|
4398
Scilex Holding
SCLX
$26.5M
| $693K | ﹤0.01% |
12,447
-7
| -0.1% | -$408 |
2023 Q1
4 quarters
|
|
4399
Emergent Biosolutions
EBS
$361M
| $692K | ﹤0.01% |
273,540
+222,583
| +437% | +$502K |
2014 Q1
40 quarters
|
|
4400
PUT
Emerson Electric
EMR
$88.8B
| $692K | ﹤0.01% |
6,100
-62,400
| -91% | -$6.41M |
2021 Q1
12 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2024 Portfolio in Review
As of Q1 2024, JP Morgan Chase held 8,132 positions worth $1.18T, up 14% from $1.04T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
JP Morgan Chase deployed $48.7B of net new capital in Q1 2024, opening 625 new positions and adding to 3,255 existing holdings. Its largest new stake was Flutter Entertainment: 1,314,201 shares worth $260M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vanguard Total International Bond ETF, an estimated $2.48B trimmed.
- JP Morgan Chase's largest Q1 2024 buy was Flutter Entertainment: 1,314,201 shares worth $260M.
- JP Morgan Chase added most to Vanguard S&P 500 ETF in Q1 2024, an estimated $4.76B increase.
- JP Morgan Chase's biggest Q1 2024 reduction was Vanguard Total International Bond ETF, cutting an estimated $2.48B.
- JP Morgan Chase fully exited BlackRock Flexible Income ETF in Q1 2024, selling an estimated $139M.
- JP Morgan Chase's ten largest holdings make up 21% of its $1.18T portfolio in Q1 2024.
- JP Morgan Chase opened 625 new positions and closed 764 in Q1 2024.
- JP Morgan Chase's portfolio value rose 14% quarter-over-quarter to $1.18T.
Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.